Use of insulin lispro in continuous subcutaneous insulin infusion treatment: Results of a multicenter trial

Diabetes Care

Volumn 22, Issue 5, 1999, Pages 784-788

  Renner, Rolf ^a   Pfützner, Andreas ^b,f   Trautmann, Michael ^c   Harzer, Oliver ^b   Sauter, Karin ^d   Landgraf, Rüdiger ^e  

^a KLINIKUM BOGENHAUSEN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c LILLY DEUTSCHLAND GMBH   (Germany)

^d LAB GmbH   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f MiniMed Europe   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HUMAN INSULIN; INSULIN LISPRO;

ADULT; ARTICLE; CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES CONTROL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PUMP; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE;

EID: 0345711504     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.5.784     Document Type: Article

References (18)

1. Home P, Capaldo B, Burrin J, Worth R, Alberti KGMM: A cross-over comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII. Diabetes Care 5:466-471, 1982
2. Fui SNT, Pickup JC, Bending JJ: Hypoglycemia and counter-regulation in insulin dependent diabetic patients: a comparison of continuous subcutaneous insulin infusion and conventional insulin injection therapy. Diabetes Care 9:221-227, 1986
3. Eichner HL, Selam JL, Hollemann CB: Reduction of severe hypoglycemic events in type 1 (insulin-dependent) diabetic patients using continuous subcutaneous insulin infusion. Diabetes Res Clin Pract 8:189-193, 1988
4. Noto RA, Ginsberg L, Lifshitz F, Pelkovitz D, Kaplan S: Improved management of brittle-psychological diabetes by use of a portable insulin infusion pump. J Pediatr 107:100-102, 1985
5. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR: [Lys (B28), Pro (B29)]-Human insulin: a rapidly absorbed analogue of human insulin. Diabetes 43:396-402, 1994
6. Anderson JH, Brunelle RL, Keohane P, Koivisto VA, Trautmann ME, Vignati L, DiMarchi R: Mealtime treatment with insulin analog improves postprandial hyperglycaemia and hypoglycemia in patients with non-insulin dependent diabetes mellitus: Multicenter Insulin Lispro Study Group. Arch Intern Med 157:1249-1255, 1997
7. Pfützner A, Küstner E, Forst T, Schulze-Schleppinghoff B, Trautmann ME, Haslbeck M, Schatz H, Beyer J: Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes. Exp Clin Endocrinol Diabetes 104:25-30, 1996
8. Anderson JH, Brunelle RL, Koivisto VA, Pfützner A, Trautmann ME, Vignati L, DiMarchi R: Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment: Multicenter Insulin Lispro Study Group. Diabetes 46:265-270, 1997
9. Bradley C: Diabetes treatment satisfaction questionnaire (DTSQ). In Handbook of Psychology and Diabetes. Bradley C, Ed. Gordon & Breach, U.K., 1994, p. 111-132
10. Lougheed WD, Zinman B, Strack TR, Frank BH: Chemical stability of insulin lispro in insulin infusion systems (Abstract). Diabetes 45 (Suppl. 2):198A, 1996
11. Zinman B, Chiasson JL, Tildesley H, Tsui E, Strack T: Insulin lispro in CSII: results of a double-blind, crossover study. Diabetes 45 (Suppl. 2):98, 1996
12. Lins PE, Johansson UB, Wredling R, Adamson U: Blood glucose variability and well-being during CSII using insulin lispro and regular human insulin (Abstract). Diabetes 47 (Suppl. 1):39A, 1998
13. Renard E, Vague V, Finget M, Guerci B, Blin P, Augendre B, Tauber JP: SC infusion of insulin lispro vs. human regular insulin by portable pumps: significant improvement of HbA1c and blood glucose stability under insulin lispro (Abstract). Diabetes 46 (Suppl. 1):605A, 1997
14. Bode BW, Steed RD, Davidson PC: Continuous subcutaneous insulin infusion (CSII): a study comparing lispro to regular human insulin. Diabetes 46 (Suppl. 1):167A, 1997
15. Ebeling P, Jansson PA, Smith U, Lalli C, Bolli G, Koivisto VA: Strategies towards improved control during insulin lispro therapy in IDDM. Diabetes Care 20:1287-1289, 1997
16. Reichel A, Rietzsch H, Köhler HJ, Pfützner A, Gudat U, Schulze J: Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro. Exp Clin Endocrinol Diabetes 106:168-172, 1998
17. Pein M, Hinselmann C, Pfützner A, Dreyer M: Catheter disconnection in type 1 diabetic patients treated with CSII: comparison of insulin lispro and human regular insulin. Diabetologia 39 (Suppl. 1):847, 1996
18. Kotsanos JG, Vignati L, Huster W, Andrejasich C, Boggs MB, Jacobson AM, Marrero D, Mathias S, Patrick D, Zalani S, Anderson J: Health-related quality-of-life results from multinational clinical trials of insulin lispro. Diabetes Care 20:948-958, 1997